Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC

Clinical trial NCT00234468 · TERMINATED

Trial details

NCT number: NCT00234468
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Non Small Cell Lung Carcinoma

Start date: 2004-01-01
Enrollment: 490

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.